• Mashup Score: 8

    Mitophagy modulators like MFN2 drive BH3-mimetic resistance in acute myeloid leukemia (AML), and genetic or pharmacologic inhibition of MFN2 improved leukemia cell elimination both in vitro and in preclinical AML patient-derived models.

    Tweet Tweets with this article
    • July issue— #Mitophagy Promotes Resistance to BH3 Mimetics in Acute Myeloid #Leukemia. https://t.co/Zz49L09zmd @glytsou @xufeng_chen Emmanouil Zacharioudakis @ProfGavathiotis @iannisaifantis1 @RutgersCancer @ae_cancercenter @EinsteinMed @Perlmutter_CC @NYUGSOM_Path @nyugrossman https://t.co/yxz905K4i4

  • Mashup Score: 0

    Actin is most frequently associated with cell migration and shape control. However, actin has a multitude of other cellular roles, including regulating the function and dynamics of organelles. This Review discusses a plethora of actin functions in mitochondrial biology.

    Tweet Tweets with this article
    • ✨ICYMI: New #NRMCBReview on the role of actin in mitochondrial biology, e.g., during mitochondrial fission, dysfunction and #mitophagy, or motility. ➡️"The multiple links between actin and mitochondria" by @TakShunFung, @raj_mito and @hhiggslab. https://t.co/LSnJE5bVbE https://t.co/r9iFnsvo7h

  • Mashup Score: 12

    Abstract. BH3-mimetics are used as an efficient strategy to induce cell death in several blood malignancies, including acute myeloid leukemia (AML). Venetoclax, a potent BCL-2 antagonist, is used clinically in combination with hypomethylating agents for the treatment of AML. Moreover, MCL-1 or dual BCL-2/BCL-xL antagonists are under investigation. Yet, resistance to single or combinatorial…

    Tweet Tweets with this article
    • #Mitophagy Promotes Resistance to BH3 Mimetics in #AcuteMyeloidLeukemia— by @glytsou, @xufeng_chen, E. Zacharioudakis, @ProfGavathiotis, @iannisaifantis1 et al. https://t.co/vxEg1gbPz2 @RutgersCancer @ae_cancercenter @EinsteinMed @Perlmutter_CC @NYUGSOM_Path @nyugrossman #leusm https://t.co/8F0mzp3Gmz